Onderneming Nexalin Technology, Inc.
Aandelen
NXL
US65345B2016
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,16 USD | -4,13% | -29,70% | +186,56% |
Vakgebied
Aantal werknemers: 6
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Licensing
74,1
%
| 0 | 6,0 % | 0 | 74,1 % | +3,65% |
Equipment
24,6
%
| 0 | 2,0 % | 0 | 24,6 % | +1,95% |
Other
1,2
%
| 0 | 2,0 % | 0 | 1,2 % | -94,82% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
96,7
%
| 0 | 8,6 % | 0 | 96,7 % | -5,64% |
China
3,3
%
| 1 | 91,4 % | 0 | 3,3 % | -99,70% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | - | 19-10-10 | |
Mark White
CEO | Chief Executive Officer | 62 | 01-01-18 |
David Owens
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-17 |
Marilyn Elson
AUD | Comptroller/Controller/Auditor | 71 | 01-01-22 |
Irene Cergnul
PRN | Corporate Officer/Principal | - | - |
Suzie Schuder
PRN | Corporate Officer/Principal | - | - |
Mark Agresti
PRN | Corporate Officer/Principal | - | - |
Joel Bradus
SAM | Sales & Marketing | - | - |
Michael Nketiah
LAW | General Counsel | 49 | 24-01-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Leslie Bernhard
CHM | Chairman | 80 | - |
Mark White
CEO | Chief Executive Officer | 62 | 01-01-18 |
Alan Kazden
BRD | Director/Board Member | 63 | 01-01-19 |
David Owens
CTO | Chief Tech/Sci/R&D Officer | 63 | 01-01-17 |
Ben V. Hu
BRD | Director/Board Member | 66 | 01-01-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 7 436 562 | 5 732 124 ( 77,08 %) | 0 | 77,08 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+186,56% | 8,63 mln. | |
+8,88% | 221 mld. | |
+8,68% | 186 mld. | |
+14,25% | 137 mld. | |
+28,18% | 109 mld. | |
+14,65% | 52,68 mld. | |
+4,48% | 50,86 mld. | |
+4,39% | 42,53 mld. | |
+7,00% | 37,76 mld. | |
+26,06% | 31,86 mld. |